ProfileGDS4132 / 202213_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 35% 35% 36% 37% 38% 37% 32% 41% 45% 34% 42% 44% 41% 48% 34% 46% 40% 31% 37% 44% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10189.280835
GSM201543Muscle PCOS pioglitazone 12180.959935
GSM201544Muscle PCOS pioglitazone 16193.62436
GSM201545Muscle PCOS pioglitazone 201101.63237
GSM201829Muscle PCOS pioglitazone 231105.38838
GSM201830Muscle PCOS pioglitazon 25199.291937
GSM201831Muscle PCOS pioglitazone 27176.341532
GSM201832Muscle PCOS pioglitazone 31104.30741
GSM201833Muscle PCOS pioglitazone 41109.5145
GSM201834Muscle PCOS pioglitazone 8182.322534
GSM201835Muscle PCOS after pioglitazone 10293.748342
GSM201836Muscle PCOS after pioglitazone 122105.28844
GSM201837Muscle PCOS after pioglitazone 16290.35141
GSM201838Muscle PCOS after pioglitazone 202116.01348
GSM201839Muscle PCOS after pioglitazone 23279.221934
GSM201840Muscle PCOS after pioglitazone 252118.31146
GSM201841Muscle PCOS after pioglitazone 27287.84540
GSM201842Muscle PCOS after pioglitazone 3260.949631
GSM201843Muscle PCOS after pioglitazone 4291.497837
GSM201844Muscle PCOS after pioglitazone 82109.42644